secwatch.observer — SEC 8-K summary
======================================

Issuer:     VIEMED HEALTHCARE, INC. (VMD)
CIK:        0001729149
Form:       8-K
Filed at:   2023-05-08T23:59:59+00:00
Accession:  0001729149-23-000061
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viemed Q1 2023 revenue record $39.6M, up 31% YoY; EBITDA $8.3M
--------------------------------------------------------------

- Net revenue of $39.6M, a record, up 31% from Q1 2022 and 6% sequentially.
- Net income of $1.5M; adjusted EBITDA of $8.3M, up 15% from Q1 2022.
- Prior-year quarter benefited from COVID-related revenue and Provider Relief Fund income.
- No specific EPS or guidance provided in the press release excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729149/000172914923000061/0001729149-23-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729149/000172914923000061/vmd-20230508.htm
  HTML page:      https://secwatch.observer/filing/0001729149-23-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer